About
Regeneron Pharmaceuticals appears at No. 436 in the 2026 Global 2000, a multi-factor ranking based on sales, profits, assets and market value. The company is headquartered in Tarrytown, New York, United States and operates primarily in drugs & biotechnology. Reported figures used for the ranking include $14.9B in sales, $4.4B in profit, $40.9B in assets and a market value of $73.2B.